Showing results (31-40 of 150) with videos related to
Sort By:
Pageof 15
Heart (British Cardiac Society)|January 20, 2004
Tachycardiomyopathy: a diagnosis not to be missedN L Walker, S M Cobbe, D H BirnieCardiovascular Research|August 1, 1991
Metoprolol and ventricular repolarisation and refractoriness: lack of chronic adaptational class III effects in rabbitS M Barr, B S Manley, S M CobbeInternational Journal of Cardiology|June 1, 1988
Spontaneous splenic rupture as complication of infective endocarditisS D Pringle, A C McCartney, S M CobbeThe American Journal of Cardiology|December 1, 1992
Effects of the class III antiarrhythmic drug dofetilide on ventricular monophasic action potential duration and QT interval dispersion in stable angina pectorisM L Sedgwick, H S Rasmussen, S M CobbeBasic Research in Cardiology|December 1, 2000
Ventricular fibrillation threshold and local dispersion of refractoriness in isolated rabbit hearts with left ventricular dysfunctionF L Burton, A R McPhaden, S M CobbeCardiovascular Research|February 1, 1993
Influence of hyperkalaemia and ischaemia on non-receptor-mediated cardiac electrophysiological effects of naloxoneK G Oldroyd, M N Hicks, S M CobbeCardiovascular Research|March 23, 2000
Heterogeneous changes in action potential and intracellular Ca2+ in left ventricular myocyte sub-types from rabbits with heart failureM A McIntosh, S M Cobbe, G L SmithCardiovascular Research|June 6, 1998
Non-uniform prolongation of intracellular Ca2+ transients recorded from the epicardial surface of isolated hearts from rabbits with heart failureG A Ng, S M Cobbe, G L SmithLancet (London, England)|August 29, 1987
Misuse of intravenous verapamil in patients with ventricular tachycardiaA C Rankin, A P Rae, S M CobbeThe American Journal of Cardiology|February 15, 1992
Clinical and electrophysiologic effects of intravenous dofetilide (UK-68,798), a new class III antiarrhythmic drug, in patients with angina pectorisM L Sedgwick, H S Rasmussen, S M CobbePageof 15